Anti-VEGF Injections (e.g., Aflibercept, Ranibizumab, Bevacizumab)

Type: drug

Status: FDA Approved

Developer: Regeneron, Genentech, Roche

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026